RSV Prevention in Latin America and the Caribbean: Proven Immediate Benefits and Potential Life-Course Value
Respiratory syncytial virus (RSV) remains a leading cause of infant lower respiratory tract infection, hospitalization, and death in Latin America and the Caribbean, where unequal access to diagnosis, medical care, oxygen, referral, and intensive care worsens outcomes. New passive immunization tools, maternal RSV prefusion F vaccination and long-acting monoclonal antibodies, can protect infants before peak vulnerability. Still, their population impact depends on timing, coverage, equity, financing, surveillance, and program design. Emerging regional experience with hybrid strategies may help close protection gaps among infants missed or insufficiently protected by maternal immunization. Severe early-life RSV disease is consistently associated with recurrent lower respiratory tract infections, wheezing, asthma, impaired lung-function trajectories, and increased health-care use. However, causality and long-term effects of current preventive products remain uncertain. A regional agenda linking maternal–infant cohorts, surveillance, equity analyses, and long-term health-economic evaluations is needed to define both the established immediate and potential longer-term public-health value of RSV prevention.
Authors
- Dora Estripeaut (ORCID: https://orcid.org/0000-0002-2042-0817)
- Andrea Parra-Buitrago (ORCID: https://orcid.org/0009-0002-9665-5791)
- Renato de Ávila Kfouri (ORCID: https://orcid.org/0000-0002-3903-8140)
- Roberto Debbag
- Flor M. Muñoz (ORCID: https://orcid.org/0000-0002-0457-7689)
- Andrés Felipe Arias (ORCID: https://orcid.org/0000-0002-8176-7267)
- Vanesa Edelvais Castellano (ORCID: https://orcid.org/0000-0003-0226-4168)
- Eva María Ruiz de Castilla
- Alfonso Javier Rodriguez-Morales (ORCID: https://orcid.org/0000-0001-9773-2192)
- Iván Felipe Gutiérrez-Tobar (ORCID: https://orcid.org/0000-0002-9614-2040)
- Mónica Pujadas (ORCID: https://orcid.org/0000-0002-6396-5163)
- Jose Manuel Brea (ORCID: https://orcid.org/0000-0002-5523-1979)
- Solana Rapaport (ORCID: https://orcid.org/0009-0008-1294-075X)
- Irene Benítez
- Carlos Torres-Martínez (ORCID: https://orcid.org/0000-0002-7427-1765)
- Maurice Mayrides
- Melissa Palmieri (ORCID: https://orcid.org/0000-0001-6450-0598)
- María Del Valle Juárez (ORCID: https://orcid.org/0000-0002-0906-4698)
- Gonzalo Pérez Marc
- Gustavo Lazo-Páez (ORCID: https://orcid.org/0009-0008-0554-9875)
- Lourdes Dueñas
- Valentina Gutiérrez (ORCID: https://orcid.org/0000-0002-5815-5035)
- Claudia Beltrán-Arroyave
- María L. Ávila-Agüero (ORCID: https://orcid.org/0000-0002-1979-0431)
- Paula Verónica Couto
- J. Esteban Bonilla
- Gabriela Zambrano
- Jesús Moisés Ramírez
- Lesly Jacinto
Publication Details
- Journal
- Vaccines
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3390/vaccines14110995
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00